{"id":802394,"date":"2026-04-15T14:14:01","date_gmt":"2026-04-15T14:14:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=802394"},"modified":"2026-04-15T14:14:01","modified_gmt":"2026-04-15T14:14:01","slug":"prefilled-syringes-market-to-reach-1453-billion-by-2031","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/prefilled-syringes-market-to-reach-1453-billion-by-2031_802394.html","title":{"rendered":"Prefilled Syringes Market to Reach $14.53 Billion by 2031"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1776238566.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Prefilled Syringes Market to Reach $14.53 Billion by 2031\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1776238566.jpg\" alt=\"Prefilled Syringes Market to Reach $14.53 Billion by 2031\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), &#038; Region \u2013 Global Forecast to 2031<\/div>\n<p style=\"text-align: justify;\"><strong>According to MarketsandMarkets&trade;, <\/strong>the global <strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/prefilled-syringes-market-16618331.html?utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Prefilled Syringes Market<\/a><\/strong> is projected to grow from <strong>USD 8.65 billion in 2026 to USD 14.53 billion by 2031<\/strong>, registering a <strong>CAGR of 10.9%<\/strong> during the forecast period. Market growth is primarily driven by the rising prevalence of chronic diseases, increasing geriatric population, and growing adoption of biologics that require precise and safe drug delivery systems.<\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure: <a rel=\"nofollow\" name=\"www_marketsandmarkets_com_pdfdownlo\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=16618331&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=16618331<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Browse<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>250 <\/strong>Market Data Tables<\/li>\n<li><strong>60 <\/strong>Figures<\/li>\n<li><strong>300 <\/strong>Pages and in-depth TOC on<strong> &#8220;<\/strong> <strong>Prefilled Syringes Market <strong>&#8211; Global Forecast to 2031&rdquo;.<\/strong><\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">The demand for convenient, ready-to-administer drug delivery solutions is accelerating across healthcare settings. Prefilled syringes offer advantages such as accurate dosing, reduced risk of contamination, and improved patient compliance, making them increasingly preferred in long-term therapies. However, stringent regulatory requirements and safety concerns associated with these devices remain key challenges, necessitating continuous innovation and rigorous quality standards.<\/p>\n<p style=\"text-align: justify;\"><strong>Key Market Insights<\/strong><\/p>\n<p style=\"text-align: justify;\">By type, the <strong>conventional prefilled syringes segment<\/strong> accounted for the largest share of the market in 2025. Their widespread use across multiple therapeutic areas is driven by ease of use, dosing accuracy, and compatibility with a wide range of drugs. Established manufacturing processes and scalability further support their dominance in the global market.<\/p>\n<p style=\"text-align: justify;\">By material, the <strong>glass prefilled syringes segment<\/strong> held the largest market share in 2025. Glass syringes are highly preferred due to their inert nature, minimizing the risk of drug interaction and ensuring stability for sensitive formulations such as biologics and vaccines. Continuous advancements in glass technology have further enhanced their durability and safety.<\/p>\n<p style=\"text-align: justify;\">By design, the <strong>single-chamber prefilled syringes segment<\/strong> dominated the market in 2025. Their simple design, cost-effectiveness, and ease of use make them widely adopted across applications such as vaccination and insulin delivery. These syringes reduce the risk of dosing errors and streamline administration processes.<\/p>\n<p style=\"text-align: justify;\"><strong>Application Insights<\/strong><\/p>\n<p style=\"text-align: justify;\">By application, the <strong>cancer segment<\/strong> accounted for the largest share of the prefilled syringes market in 2025. The growing demand for precise and targeted drug delivery in oncology treatments is driving adoption. Prefilled syringes enable accurate administration of chemotherapeutics, monoclonal antibodies, and supportive care drugs, contributing to improved patient outcomes and treatment efficiency.<\/p>\n<p style=\"text-align: justify;\"><strong>Regional Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>North America<\/strong> held the largest share of the prefilled syringes market in 2025. The region&rsquo;s dominance is attributed to advanced healthcare infrastructure, high adoption of innovative medical technologies, and strong investments in pharmaceutical R&amp;D. Additionally, the increasing prevalence of chronic diseases and the presence of leading pharmaceutical and biotechnology companies continue to support market growth.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages: <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=16618331&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=16618331<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Competitive Landscape<\/strong><\/p>\n<p style=\"text-align: justify;\">The prefilled syringes market is highly competitive, with key players focusing on product innovation, partnerships, and expansion strategies. Major companies operating in this market include BD, Gerresheimer AG, SCHOTT, West Pharmaceutical Services, Inc., AptarGroup Inc., Nipro, Baxter, Owen Mumford Ltd., Weigao Medical International Co., Ltd., Credence MedSystems, Inc., Novartis AG, Stevanato Group, Polymedicure, MedXL, Sharps Technology, Inc., Fresenius Kabi, DBM S.R.L., Taisei Kako Co., Ltd., Shandong Province Medicinal Glass Co., Ltd., SHIN YAN SHENO PRECISION INDUSTRIAL CO., LTD., J.O. Pharma Co., Ltd., BMIKOREA, B. Braun SE, and Al Shifa Medical Products Co.<\/p>\n<p style=\"text-align: justify;\">As the demand for safe, efficient, and patient-friendly drug delivery systems continues to rise, the prefilled syringes market is expected to witness robust growth, driven by technological advancements and expanding therapeutic applications.<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=6249609&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Fill Finish Manufacturing Market<\/a> &#8211; Global Forecast to 2030<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=1085&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Pharmaceutical Drug Delivery Market<\/a> &#8211; Global Forecast to 2029<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_145966.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Rohan Salgarkar<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=prefilled-syringes-market-to-reach-1453-billion-by-2031\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>1615 South Congress Ave.  Suite 103, Delray Beach, FL 33445<br \/><strong>City:<\/strong> Florida<br \/><strong>State:<\/strong> Florida<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/prefilled-syringes-market-16618331.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/prefilled-syringes-market-16618331.html<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=prefilled-syringes-market-to-reach-1453-billion-by-2031\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), &#038; Region \u2013 Global Forecast to 2031 According to MarketsandMarkets&trade;, the global Prefilled Syringes Market is projected &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/prefilled-syringes-market-to-reach-1453-billion-by-2031_802394.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,411,404],"tags":[],"class_list":["post-802394","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Technology","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/802394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=802394"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/802394\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=802394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=802394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=802394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}